Lymph Node Pathologic Grading Strategy

RecruitingOBSERVATIONAL
Enrollment

2,998

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

April 20, 2025

Conditions
Lung Adenocarcinoma
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER